2019 EULAR建议:成人自身免疫性炎症性风湿性疾病的疫苗接种(更新版)

2019-08-14 欧洲抗风湿病联盟 Ann Rheum Dis. 2019 Aug 14

2019年8月,欧洲抗风湿病联盟(EULAR)更新了成人自身免疫性炎症性风湿性疾病的疫苗接种建议,本文是对2011版建议的更新,最新的建议共涉及6相总体原则和9条推荐意见。

中文标题:

2019 EULAR建议:成人自身免疫性炎症性风湿性疾病的疫苗接种(更新版)

英文标题:

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

发布机构:

欧洲抗风湿病联盟

发布日期:

2019-08-14

简要介绍:

2019年8月,欧洲抗风湿病联盟(EULAR)更新了成人自身免疫性炎症性风湿性疾病的疫苗接种建议,本文是对2011版建议的更新,最新的建议共涉及6相总体原则和9条推荐意见。

 

拓展指南:风湿相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 EULAR建议:成人自身免疫性炎症性风湿性疾病的疫苗接种(更新版))] GetToolGuiderByIdResponse(projectId=1, id=725b01c001e8a660, title=2019 EULAR建议:成人自身免疫性炎症性风湿性疾病的疫苗接种(更新版), enTitle=2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases., guiderFrom=Ann Rheum Dis. 2019 Aug 14, authorId=null, author=, summary=2019年8月,欧洲抗风湿病联盟(EULAR)更新了成人自身免疫性炎症性风湿性疾病的疫苗接种建议,本文是对2011版建议的更新,最新的建议共涉及6相总体原则和9条推荐意见。 , cover=, journalId=null, articlesId=null, associationId=258, associationName=欧洲抗风湿病联盟, associationIntro=null, copyright=0, guiderPublishedTime=Wed Aug 14 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年8月,欧洲抗风湿病联盟(EULAR)更新了成人自身免疫性炎症性风湿性疾病的疫苗接种建议,本文是对2011版建议的更新,最新的建议共涉及6相总体原则和9条推荐意见。 </P> <P> </P>拓展指南:<strong>与<font color=red>风湿</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=2bd981c001e79832" title="2019 EULAR建议:风湿病学卫生专业人员的通用核心能力" target=_blank>2019 EULAR建议:风湿病学卫生专业人员的通用核心能力</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=441461c001e1a250" title="糖皮质激素在儿童风湿病中应用专家共识(下)" target=_blank>糖皮质激素在儿童风湿病中应用专家共识(下)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=bed7e1c001e12a8a" title="2018 APLAR建议:类风湿性关节炎的治疗(更新版)" target=_blank>2018 APLAR建议:类风湿性关节炎的治疗(更新版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5bcf41c00169016e" title="2018年《国际儿童风湿病试验组织(PRINTO)幼年特发性关节炎新分类标准专家共识(启动步骤)》中国专家解读" target=_blank>2018年《国际儿童风湿病试验组织(PRINTO)幼年特发性关节炎新分类标准专家共识(启动步骤)》中国专家解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=d67fd1c0016836cc" title="2018 意大利共识建议:类风湿性关节炎丙型肝炎感染的管理" target=_blank>2018 意大利共识建议:类风湿性关节炎丙型肝炎感染的管理</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E9%A3%8E%E6%B9%BF" target=_blank>有关风湿更多指南</a></ul>, tagList=[TagDto(tagId=93734, tagName=成人自身免疫性炎症性风湿性疾病), TagDto(tagId=7819, tagName=疫苗接种)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=24168, appHits=177, showAppHits=7, pcHits=22457, showPcHits=2385, likes=77, shares=6, comments=2, approvalStatus=1, publishedTime=Tue Aug 27 21:16:57 CST 2019, publishedTimeString=2019-08-14, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Aug 27 21:16:57 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 00:17:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 EULAR建议:成人自身免疫性炎症性风湿性疾病的疫苗接种(更新版))])
2019 EULAR建议:成人自身免疫性炎症性风湿性疾病的疫苗接种(更新版)
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=959270, encodeId=2eb89592e08d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Thu Apr 22 08:14:55 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371897, encodeId=e8833e1897a0, content=求汉化版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/20/dafb36f63f4241903de36c3d053babb8.jpg, createdBy=d367105945, createdName=Midas, createdTime=Wed Aug 28 06:50:21 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2021-04-22 ms9000001532925281

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=959270, encodeId=2eb89592e08d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58d25483500, createdName=ms9000001532925281, createdTime=Thu Apr 22 08:14:55 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371897, encodeId=e8833e1897a0, content=求汉化版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/20/dafb36f63f4241903de36c3d053babb8.jpg, createdBy=d367105945, createdName=Midas, createdTime=Wed Aug 28 06:50:21 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2019-08-28 Midas

    求汉化版

    0